Michael R Megna
Chief Accounting Officer at Kiniksa Pharmaceuticals International, plc (KNSA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 3SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 4,60029,062 held (−14%) | $80.30 | $369K | -2.1% |
| Apr 13SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 6,62527,418 held (−19%) | $46.69 | $309K | +68.3% |
| Oct 22SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 37,25540,281 held (−48%) | $38.72 | $1.4M | +103.0% |
| Oct 22SEC | KNSAKiniksa Pharmaceuticals International, plc | Sell Plan | 13,23527,046 held (−33%) | $39.31 | $520K | +99.9% |
- Sell
Chief Accounting Officer Michael R Megna sold $369K of KNSA at $80.30 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Michael R Megna sold $309K of KNSA at $46.69 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Michael R Megna sold $1.4M of KNSA at $38.72 — cuts the stake by 48%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Accounting Officer Michael R Megna sold $520K of KNSA at $39.31 — cuts the stake by 33%; pre-scheduled 10b5-1 plan sale.